Iktos Collabs with Kadmon to Use AI for New Drug Design
Iktos, a company specializing in Artificial Intelligence for new drug design, today announced that it has entered into a Research Collaboration Agreement with Kadmon, a...
Category : Clinical Intelligence/Clinical Efficiency
Medical Intelligence Platform Dr.Evidence Expands Sr. Leadership
Unveils New Identity Emblematic of Purpose: Accelerated Impact™ Dr.Evidence™, the leading medical intelligence platform for life sciences companies, today announced a slate of key commercial...
Huma Raises $130M Financing to Scale Digital Health Platform
The investment arms of leading health and technology companies, Bayer, Hitachi, Samsung, Sony Innovation Fund by IGV, Unilever and the PE fund HAT, are financing...
Interline Therapeutics Launches With $92 Million
Investment from Foresite Capital and ARCH Venture Partners will support platform development and therapeutic programs focused on inflammatory disease and cancer Interline Therapeutics, a Foresite...
Exscientia Announces Second Molecule Created Using AI
Second clinical molecule from Exscientia collaboration with Sumitomo Dainippon Pharma to begin Phase 1 trials in United States. Clinical study of DSP-0038, a dual targeted...
Iktos and Facio Therapies Collab to Use AI for FSHD Drug Design
Iktos, a company specialized in Artificial Intelligence for new drug design, and Facio Therapies, a drug discovery and development company focused on developing treatments for...
Pfizer & BioNTech Authorized for COVID Vaccine Emergency Use in Adolescents
In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years Data also submitted to...
Healthtech Heartbeat Health Raises $20M to Expand Virtual Heart Care
Heartbeat Health, a healthcare company working to deliver the most effective, efficient, and engaging heart care, announced today that it has raised $20 million in...
Leading mRNA Vaccine Company Moderna Announces Expansion of MTC
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced an expansion of the Moderna Technology Center (MTC) in Norwood,...
Altru Health System Powers Clinical Trial Offering with Deep Lens
VIPER™ will identify and match eligible patients to oncology clinical trials faster and with improved efficiencies across Altru Health System’s network Deep Lens and Altru...